Literature DB >> 9033294

Surgical results and prognostic factors in early non-small cell lung cancer.

J Padilla1, V Calvo, J C Peñalver, G Sales, A Morcillo.   

Abstract

BACKGROUND: We attempted to clarify the prognostic value of tumor size (maximum, 3 cm), the evidence of invasion proximal to a lobar bronchus at least 2 cm distal to the carina, and the absence or presence of visceral pleura invasion in patients with completely resected non-small cell lung carcinoma without lymph node invasion or satellite lesions (T1 N0 M0, T2 N0 M0).
METHODS: The study included 158 patients. Four patients were excluded due to postoperative mortality (2.5%). The variables selected for the survival study were sex, age, symptoms presence or absence, bronchial invasion level (evidence or not of invasion proximal to a lobar bronchus at least 2 cm distal to the carina), pulmonary location, pneumonectomy or lesser resection, cell type, squamous or nonsquamous, tumor size, invasion or not of the visceral pleura, and T1 or T2 status.
RESULTS: The overall survival rate in this series was 74% at 5 years and 60% at 10 years. Only the tumor size had a significant influence on survival (p = 0.0092). Patients with a tumor less than 2 cm in diameter did better (p = 0.0023).
CONCLUSIONS: These observations suggest that it will be necessary to further research in clarifying the prognostic value of the bronchial invasion level and of the degree of the visceral pleura invasion and its implications when classifying a tumor as T1 or T2.

Entities:  

Mesh:

Year:  1997        PMID: 9033294     DOI: 10.1016/s0003-4975(96)01034-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer.

Authors:  Zachary S Morris; Donald M Cannon; Brett A Morris; Søren M Bentzen; Kevin R Kozak
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609

2.  Evaluation of the 7th edition of the TNM classification for lung cancer at a single institution.

Authors:  Jia Wang; Nan Wu; Qingfeng Zheng; Yuan Feng; Shi Yan; Chao Lv; Shaolei Li; Yuzhao Wang; Yue Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-28       Impact factor: 4.553

3.  Biplane correlation imaging: a feasibility study based on phantom and human data.

Authors:  Ehsan Samei; Nariman Majdi-Nasab; James T Dobbins; H Page McAdams
Journal:  J Digit Imaging       Date:  2012-02       Impact factor: 4.056

4.  Previous tumour as a prognostic factor in stage I non-small cell lung cancer.

Authors:  Angel López-Encuentra; Agustín Gómez de la Cámara; Ramón Rami-Porta; José Luis Duque-Medina; José Luis Martín de Nicolás; Javier Sayas
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

5.  Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.

Authors:  Daniel Morgensztern; Lingling Du; Saiama N Waqar; Aalok Patel; Pamela Samson; Siddhartha Devarakonda; Feng Gao; Cliff G Robinson; Jeffrey Bradley; Maria Baggstrom; Ashiq Masood; Ramaswamy Govindan; Varun Puri
Journal:  J Thorac Oncol       Date:  2016-06-08       Impact factor: 15.609

6.  Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm.

Authors:  Run-Bin Liang; Peng Li; Bob T Li; Jie-Tian Jin; Valerie W Rusch; David R Jones; Yi-Long Wu; Qing Liu; Jie Yang; Mu-Zi Yang; Shuo Li; Hao Long; Jian-Hua Fu; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong; Xue Hou; Su-Xia Lin; Hao-Xian Yang
Journal:  Chest       Date:  2021-03-18       Impact factor: 9.410

7.  Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.

Authors:  Pei Zhang; Jianchun Duan; Hua Bai; Zhijie Wang; Shugeng Gao; Fengwei Tan; Yushun Gao; Xin Wang; Rui Wan; Jiachen Xu; Xiran He; Xiaoshuang Feng; Ruofei Yu; Jing Sun; Zhe Zhao; Kailun Fei; Ni Li; Jie He; Jie Wang
Journal:  Thorac Cancer       Date:  2020-10-27       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.